AIFM1 and chronic myelogenous leukemia, BCR-ABL1 positive: To evaluate the apoptosis pathway activated by pristimerin, CML cells were exposed to pristimerin, cytochrome c and AIF in the cytosolic fraction was examined by Western blotting at different time points.